Brief: Tiziana Life Sciences Awarded $4 Mln Grant By National Institutes Of Health
19/09/2024 12:42
Sept 19 (Reuters) - Tiziana Life Sciences Ltd TLSA.O :
* TIZIANA LIFE SCIENCES ANNOUNCES $4 MILLION GRANT AWARDED
BY
NATIONAL INSTITUTES OF HEALTH TO STUDY ANTI-CD3 IN ALZHEIMER’S
DISEASE
* TIZIANA LIFE SCIENCES LTD - TO INITIATE FIRST-IN-HUMAN
CLINICAL
TRIALS FOR ALZHEIMER'S
Source text for Eikon: ID:nGNX2WVLJl
Further company coverage: TLSA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tiziana Life Sciences
See all newsTiziana's experimental MS treatment meets main goals in mid-stage study
Brief: Tiziana Life Sciences - Submits Request To FDA For Orphan Drug Designation For Intranasal Foralumab For Msa
Brief: Tiziana Announces Last Patient Completes Last Visit In Phase 2A Inform-MS Trial Of Intranasal Foralumab
Brief: Tiziana Announces Last Patient Successfully Dosed In Its Phase 2 Inform-MS Trial
Brief: Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis